Page last updated: 2024-10-25

cyproheptadine and Vestibular Diseases

cyproheptadine has been researched along with Vestibular Diseases in 1 studies

Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.

Vestibular Diseases: Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.

Research Excerpts

ExcerptRelevanceReference
"Vestibular neuronitis was described in 1949 and 1952 by Dix and Hallpike."1.32The use of antiserotonin drugs in the nucleoreticular vestibular syndrome: preliminary observations. ( Lehrer, JF, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lehrer, JF1

Other Studies

1 other study available for cyproheptadine and Vestibular Diseases

ArticleYear
The use of antiserotonin drugs in the nucleoreticular vestibular syndrome: preliminary observations.
    The international tinnitus journal, 2004, Volume: 10, Issue:1

    Topics: Brain Stem; Cyproheptadine; Female; Follow-Up Studies; Humans; Male; Postural Balance; Serotonin Ant

2004